PPP1R14D activators belong to a class of chemical compounds that interact with a specific protein known as protein phosphatase 1 regulatory inhibitor subunit 14D (PPP1R14D). This protein is part of a larger family of proteins that play crucial roles in the regulation of cellular functions through their involvement in the process of phosphorylation and dephosphorylation. Phosphorylation is a biochemical process that modifies the activity of proteins by attaching phosphate groups, while dephosphorylation removes these groups. Protein phosphatases, such as the one associated with PPP1R14D, are enzymes that catalyze the removal of phosphate groups from proteins, an action that can alter the function, location, or interaction of the target protein within the cell.
Activators of PPP1R14D have the ability to modulate the activity of this regulatory protein, which in turn can influence the activity of the associated phosphatase. By binding to PPP1R14D, these activators can enhance or diminish the protein's inhibitory effect on the phosphatase, thereby regulating the dephosphorylation of specific substrates within the cell. The precise mechanisms by which PPP1R14D activators exert their influence on the protein can vary and may involve changes in the conformation of PPP1R14D, which can affect its interaction with the phosphatase or its ability to bind to other cellular components. The activity of these activators is of significant interest in the study of cellular signaling pathways, as the balance of phosphorylation and dephosphorylation is essential for the maintenance of numerous cellular processes, including but not limited to cell division, growth, and metabolism. Understanding the function of PPP1R14D activators thus contributes to a broader comprehension of cellular regulation and the intricate networks that sustain cellular homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels, which can lead to activation of PKA. PKA phosphorylates PPP1R14D, inhibiting its ability to suppress PP1, thereby enhancing PP1 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases like PP2A and PP1, which can result in a compensatory increase in PPP1R14D activity to regulate PP1 signaling balance. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, similar to Okadaic Acid, inhibits PP1 and PP2A activity. This can indirectly lead to an upregulation of PPP1R14D activity to maintain cellular homeostasis. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin raises intracellular calcium levels by inhibiting the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), which can modify the phosphorylation status of PPP1R14D, altering its activity. | ||||||
Phorbol-12,13-dibutyrate | 37558-16-0 | sc-202285 | 1 mg | $124.00 | 3 | |
PDBu is a PKC activator that can phosphorylate substrates including PPP1R14D, thereby influencing its interaction with and regulation of PP1. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, potentially affecting the phosphorylation state and function of PPP1R14D. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid influences gene expression and signal transduction pathways that can lead to post-translational modifications of proteins, potentially affecting PPP1R14D activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that may reduce competitive phosphorylation, potentially enhancing the specificity and function of PPP1R14D as a modulator of PP1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP, a cAMP analog, can stimulate PKA activity, which in turn can phosphorylate and regulate proteins such as PPP1R14D, modulating its activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a PKC inhibitor that can alter downstream phosphorylation events, potentially impacting PPP1R14D's regulatory roles. | ||||||